Pharmacodynamic principles and mechanisms of drug interactions

Antiepileptic Drugs: Combination Therapy and Interactions

Volumn , Issue , 2005, Pages 181-192

  Bourgeois, Blaise F D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37349066198     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545023.011     Document Type: Chapter

References (27)

1. Albright P, Bruni J. Reduction of polytherapy in epileptic patients. Arch Neurol1985; 42: 797–799.
2. Bennett HS, Dunlop T, Ziring P. Reduction of polypharmacy for epilepsy in an institution for the retarded. Dev Med Child Neurol1983; 25: 735–737.
3. Biraben A, Allain H, Scarabin JM, et al. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology2000; 55: 1758.
4. Bryant III AE, Dreifuss FE. Valproic acid hepatic fatalities. III. U. S. experience since 1986. Neurology1996; 46: 465–469.
5. Corda D, Gelisse P, Genton P, et al. Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes. Epilepsia2001; 42: 754–759.
6. Deckers CL, Hekster YA, Keyser A, et al. Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia1997; 38(5): 570–575.
7. Deckers CL, Czuczwar SJ, Hekster YA, et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia2000; 41: 1364–1374.
8. Deckers CL, Hekster YA, Keyser A, et al. Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia2001; 42: 1387–1394.
9. Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology2001; 57: 1416–1421.
10. Fischbacher E. Effect of reduction of anticonvulsants on wellbeing. Br Med J1982; 285: 423–424.
11. Genton P, Gelisse P, Thomas P, et al. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology2000; 55: 1106–1109.
12. Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia1998; 39: S2–S10.
13. Guerrini R, Belmonte A, Parmeggiani L, et al. Myoclonic status epilepticus following highdosage lamotrigine therapy. Brain Dev1999; 21: 420–424.
14. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia1994; 35: 1026–1028.
15. Macdonald R. Is there a mechanistic basis for rational polypharmacy? Epilepsy Res1996; 11: 79–93.
16. Marescaux C, Warter JM, Micheletti G, et al. Stuporous episodes during treatment with sodium valproate: report of seven cases. Epilepsia1982; 23: 297–305.
17. Meinardi H. Use of combined antiepileptic drug therapy. In Antiepileptic Drugs, 4th edn. R. H. Levy, R. H. Mattson, B. S. Meldrum, eds. New York: Raven Press, 1995: 91–97.
18. Obeid T, Panayiotopoulos CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia1989; 30: 603–606.
19. Pellock JM, Hunt PA. A decade of modern epilepsy therapy in institutionalized mentally retarded patients. Epilepsy Res1996; 25(3): 263–268.
20. Perucca E. Pharmacological principles as a basis for polytherapy. Acta Neurol Scand1995; 162(Suppl.): 31–34.
21. Sackellares JC, Lee SI, Dreifuss FE. Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia1979; 20: 697–703.
22. Schmidt D. Reduction of two-drug therapy in intractable epilepsy. Epilepsia1983; 24: 368–376.
23. Shield WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology1983; 33: 1487–1489.
24. Snead OC, Hosey LC. Exacerbation of seizures in children by carbamazepine. New Engl J Med1985; 313: 916–921.
25. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia1994; 35: 1154–1159.
26. Theodore WH, Porter RJ. Removal of sedative-hypnotic antiepileptic drugs from the regimen of patients with intractable epilepsy. Ann Neurol1983; 13: 320–324.
27. Zaccara G, Paganini M, Campostrini R, et al. Effect of associated antiepileptic treatment on valproate-induced hyperammonemia. Ther Drug Monit1985; 7: 185–190.